National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting, 59169 [2021-23318]

Download as PDF Federal Register / Vol. 86, No. 204 / Tuesday, October 26, 2021 / Notices no later than 11:59 p.m. EDT on November 19, 2021. ADDRESSES: All comments should be emailed to CAPT Samuel Wu at Samuel.Wu@hhs.gov. Please use the subject line ‘‘OMH RFI: CIIHE NHPI’’. Submitted comments received after the deadline will not be reviewed. Please respond concisely and in plain language. You may use any structure or layout that presents your information well. You may respond to some or all of our four questions below, and you can suggest other factors or relevant questions. You may also include links to online materials or interactive presentations. Proprietary information should be marked clearly and placed it in a separate section or file. Your response will become government property, and we may publish some of its non-proprietary content. FOR FURTHER INFORMATION CONTACT: CAPT Samuel Wu atSamuel.Wu@ hhs.gov. SUPPLEMENTARY INFORMATION: Authorized under Section 1707 of the Public Health Service Act, 42 U.S.C. 300u–6, as amended, the mission of OMH is to improve the health of racial and ethnic minority populations through the development of health policies and programs that help eliminate health disparities. OMH awards and other activities are intended to support the identification of effective policies, programs, and practices for improving health outcomes and to promote the sustainability and dissemination of these approaches. Under the authority of Public Law 116–260 (2021 Consolidated Appropriations Act), Congress directed OMH to create a Center to support education, service and policy development, and research advancing indigenous solutions that ultimately address health disparities among NHPI and AI/AN populations. I. Background Information NHPI communities experience persistent health disparities, including higher rates of diabetes, high blood pressure, and obesity, compared to nonHispanic white populations. Identification and awareness of health outcomes and health determinants are essential steps toward reducing health disparities in minority communities at greatest risk. Research has shown that culturally adapted and culturally grounded health and public health approaches and interventions that are aligned with indigenous communities’ cultural values and perspectives are effective in improving clinical outcomes within NHPI and AI/AN communities. VerDate Sep<11>2014 22:39 Oct 25, 2021 Jkt 256001 Program Information In September 2021, OMH announced awards to establish a Center for Indigenous Innovation and Health Equity, for which OMH will provide the organizational structure and operational framework. The Center will support efforts including education, service and policy development, and research related to advancing sustainable solutions to address health disparities and advance health equity in the AI/AN and NHPI populations. Two award recipients will function as a single initiative, coordinated by OMH. Each award recipient will focus on one of the two focus populations: AI/AN or NHPI populations. OMH expects the award recipients to implement the Center by: (1) Managing the Center advisory board; (2) partnering with academic institutions, indigenous leaders, and NHPI and AI/AN communities on Center activities; (3) identifying and disseminating culturally appropriate evidence-based and/or evidence-informed interventions, and lessons learned; and (4) designing and providing education and training to support community capacity-building. The Center’s activities are expected to result in: (1) Increased community capacity and knowledge of culturally appropriate, evidence-based and/or evidenceinformed interventions, and policies that address health disparities among NHPI and AI/AN populations; (2) increased utilization of effective strategies to reduce NHPI and AI/AN health disparities; and (3) improved NHPI and AI/AN health and reduction of health disparities. III. Questions • Are there priority health disparity issue(s) affecting NHPI communities that the Center should address? • How can the Center engage community partners to increase knowledge and adoption of culturally appropriate, evidence-based, and/or evidence-informed interventions, and policies that reduce health disparities among NHPI populations? • What should the Center consider when disseminating public health messages or promising practices Fmt 4703 Sfmt 4703 Dated: October 18, 2021. Samuel Wu, CAPT, Public Health Advisor. [FR Doc. 2021–23200 Filed 10–25–21; 8:45 am] BILLING CODE 4150–29–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Neurological Disorders and Stroke Special Emphasis Panel, November 1, 2021, 09:00 a.m. to November 2, 2021, 06:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 which was published in the Federal Register on October 13, 2021, FR Doc 2021– 22196, 86 FR 56965. This notice is being amended to change the dates of this meeting from November 1–2, 2021 to November 15– 16, 2021. The meeting time remains the same. The meeting is closed to the public. Dated: October 21, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P Through this RFI and notice of a listening session, OMH is seeking information from NHPI communities, NHPI-serving organizations, and interested parties on the questions below. Frm 00058 designed to reduce health disparities to diverse NHPI communities? • What should the Center consider when addressing barriers to implementing culturally appropriate interventions and policies to advance indigenous health innovation and health equity? [FR Doc. 2021–23318 Filed 10–25–21; 8:45 am] II. Request for Information PO 00000 59169 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of an Exclusive Patent License: Development and Commercialization of CRISPREngineered T Cell Therapies for the Treatment of Cancer AGENCY: National Institutes of Health, HHS. ACTION: Notice. The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to SUMMARY: E:\FR\FM\26OCN1.SGM 26OCN1

Agencies

[Federal Register Volume 86, Number 204 (Tuesday, October 26, 2021)]
[Notices]
[Page 59169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23318]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute of Neurological Disorders and Stroke Special Emphasis Panel, 
November 1, 2021, 09:00 a.m. to November 2, 2021, 06:00 p.m., National 
Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, 
Rockville, MD 20852 which was published in the Federal Register on 
October 13, 2021, FR Doc 2021-22196, 86 FR 56965.
    This notice is being amended to change the dates of this meeting 
from November 1-2, 2021 to November 15-16, 2021. The meeting time 
remains the same. The meeting is closed to the public.

    Dated: October 21, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-23318 Filed 10-25-21; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.